Suppr超能文献

新型冠状病毒肺炎药物的作用机制与不良反应:基础综述

Mechanism and adverse effects of COVID-19 drugs: a basic review.

作者信息

Mohammad Zadeh Nadia, Mashinchi Asl Nazli Sadat, Forouharnejad Khatereh, Ghadimi Keyvan, Parsa Sara, Mohammadi Sima, Omidi Ashkan

机构信息

School of Medicine, Islamic Azad University Tehran Faculty of Medicine Tehran, Iran.

Postdoc Associate, Texas Medical Center Texas, USA.

出版信息

Int J Physiol Pathophysiol Pharmacol. 2021 Aug 15;13(4):102-109. eCollection 2021.

Abstract

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronavirus disease 2019 (COVID-19) is chronic, inflammatory. Although the exact mechanisms of COVID-19 have not been yet discovered some drugs are found helpful for its treatment. These drugs which are divided into some lines therapies, have demonstrated to be helpful for COVID-19 patients based on immune basic and its antiviral properties of the disease. Previous studies have been indicated that deterioration of COVID-19 condition is associated with a weaker immune system. Most of these therapies impact on the immune system and immune cells. Beside many beneficial effects of these drugs, some adverse effects (AE) have been reported in many experiments and clinical trials among patients suffering from COVID-19. In this review, we conclude some AEs of vitamin-D, zinc, remdesivir, hydroxychloroquine or chloroquine, azithromycin, dexamethasone, amantadine, aspirin reported in different papers and we continue the rest of the drugs in second part of our review article.

摘要

2019冠状病毒病(COVID-19)是由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的一种传染病。2019冠状病毒病(COVID-19)是慢性炎症性疾病。尽管COVID-19的确切机制尚未被发现,但已发现一些药物对其治疗有帮助。这些药物分为几类治疗方法,基于该疾病的免疫基础及其抗病毒特性,已证明对COVID-19患者有帮助。先前的研究表明,COVID-19病情的恶化与免疫系统较弱有关。这些治疗方法大多会影响免疫系统和免疫细胞。除了这些药物的许多有益作用外,在许多针对COVID-19患者的实验和临床试验中还报告了一些不良反应(AE)。在本综述中,我们总结了不同论文中报道的维生素D、锌、瑞德西韦、羟氯喹或氯喹、阿奇霉素、地塞米松、金刚烷胺、阿司匹林的一些不良反应,我们将在综述文章的第二部分继续讨论其余药物。

相似文献

8
The journey of remdesivir: from Ebola to COVID-19.瑞德西韦的历程:从埃博拉到新冠病毒。
Drugs Context. 2020 May 22;9. doi: 10.7573/dic.2020-4-14. eCollection 2020.

引用本文的文献

本文引用的文献

7
Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review.瑞德西韦在 2019 冠状病毒病大流行中的应用:小型综述。
J Microbiol Immunol Infect. 2021 Feb;54(1):27-36. doi: 10.1016/j.jmii.2020.09.002. Epub 2020 Oct 5.
10
The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis.锌补充剂对 COVID-19 发病机制的潜在影响。
Front Immunol. 2020 Jul 10;11:1712. doi: 10.3389/fimmu.2020.01712. eCollection 2020.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验